BR9606409A - Composto opticamente ativo composição farmacêutica processos para inibir agregação de plaqueta em um animal de sangue quente ligação de fibrinogênio a gpiib/iia em um animal de sangue quente e eventos trombóticos que acompanham agnina instável em animal de sangue quente e uso do composto opticamante ativo - Google Patents

Composto opticamente ativo composição farmacêutica processos para inibir agregação de plaqueta em um animal de sangue quente ligação de fibrinogênio a gpiib/iia em um animal de sangue quente e eventos trombóticos que acompanham agnina instável em animal de sangue quente e uso do composto opticamante ativo

Info

Publication number
BR9606409A
BR9606409A BR9606409A BR9606409A BR9606409A BR 9606409 A BR9606409 A BR 9606409A BR 9606409 A BR9606409 A BR 9606409A BR 9606409 A BR9606409 A BR 9606409A BR 9606409 A BR9606409 A BR 9606409A
Authority
BR
Brazil
Prior art keywords
warm
active compound
optically active
blooded animal
blooded
Prior art date
Application number
BR9606409A
Other languages
English (en)
Portuguese (pt)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of BR9606409A publication Critical patent/BR9606409A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
BR9606409A 1995-06-01 1996-05-28 Composto opticamente ativo composição farmacêutica processos para inibir agregação de plaqueta em um animal de sangue quente ligação de fibrinogênio a gpiib/iia em um animal de sangue quente e eventos trombóticos que acompanham agnina instável em animal de sangue quente e uso do composto opticamante ativo BR9606409A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (fr) 1995-06-01 1996-05-28 Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyrique inhibiteur d'adhesion cellulaire

Publications (1)

Publication Number Publication Date
BR9606409A true BR9606409A (pt) 1997-09-30

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606409A BR9606409A (pt) 1995-06-01 1996-05-28 Composto opticamente ativo composição farmacêutica processos para inibir agregação de plaqueta em um animal de sangue quente ligação de fibrinogênio a gpiib/iia em um animal de sangue quente e eventos trombóticos que acompanham agnina instável em animal de sangue quente e uso do composto opticamante ativo

Country Status (31)

Country Link
EP (1) EP0796247A1 (fr)
JP (1) JP2885941B2 (fr)
KR (1) KR100245957B1 (fr)
AT (1) AT406675B (fr)
AU (1) AU710105B2 (fr)
BE (1) BE1009520A5 (fr)
BR (1) BR9606409A (fr)
CA (1) CA2194397A1 (fr)
CH (1) CH691808A5 (fr)
CZ (1) CZ26997A3 (fr)
DE (1) DE19680509T1 (fr)
DK (1) DK10697A (fr)
ES (1) ES2137886B1 (fr)
FI (1) FI970393A (fr)
GB (1) GB2304340B (fr)
GR (1) GR1002702B (fr)
HU (1) HUP9700274A3 (fr)
IE (1) IE960405A1 (fr)
IL (1) IL118477A0 (fr)
IT (1) IT1290839B1 (fr)
LU (1) LU90008B1 (fr)
MC (1) MC2418A1 (fr)
MX (1) MX9700379A (fr)
NL (1) NL1003243C2 (fr)
NO (1) NO307460B1 (fr)
NZ (1) NZ308597A (fr)
PL (1) PL318440A1 (fr)
SE (1) SE510812C2 (fr)
SK (1) SK13097A3 (fr)
TR (1) TR199700020T1 (fr)
WO (1) WO1996038416A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (fr) * 1982-07-28 1985-03-27 The Upjohn Company Hétéroalkysylalkanoles 3-pyridinyliques, leurs acides alkanoiques et leurs esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
DK0825184T3 (da) * 1993-03-29 2001-09-10 Astrazeneca Ab Heterocykliske derivater som blodpladeaggregeringsinhibitorer
IL109145A0 (en) * 1993-03-29 1994-06-24 Zeneca Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
GB2304340B (en) 1998-07-29
WO1996038416A1 (fr) 1996-12-05
AU710105B2 (en) 1999-09-16
KR970704689A (ko) 1997-09-06
FI970393A0 (fi) 1997-01-30
HUP9700274A3 (en) 2000-02-28
PL318440A1 (en) 1997-06-09
IE960405A1 (en) 1996-12-11
ITMI961113A1 (it) 1997-12-01
KR100245957B1 (ko) 2000-04-01
ATA900596A (de) 1999-12-15
HUP9700274A2 (hu) 1999-06-28
SE9700203L (sv) 1997-01-24
HU9700274D0 (en) 1997-04-28
BE1009520A5 (fr) 1997-04-01
AT406675B (de) 2000-07-25
EP0796247A1 (fr) 1997-09-24
ITMI961113A0 (it) 1996-05-31
SE510812C2 (sv) 1999-06-28
IL118477A0 (en) 1996-09-12
GR1002702B (el) 1997-05-22
CZ26997A3 (en) 1997-08-13
MX9700379A (es) 1997-04-30
JP2885941B2 (ja) 1999-04-26
TR199700020T1 (tr) 1997-04-22
FI970393A (fi) 1997-01-30
SE9700203D0 (sv) 1997-01-24
CA2194397A1 (fr) 1996-12-05
DE19680509T1 (de) 1997-12-04
NO970437D0 (no) 1997-01-31
LU90008B1 (fr) 1997-04-16
NO307460B1 (no) 2000-04-10
NZ308597A (en) 1998-11-25
AU5827296A (en) 1996-12-18
JPH09512836A (ja) 1997-12-22
NL1003243C2 (nl) 1996-12-04
CH691808A5 (de) 2001-10-31
ES2137886B1 (es) 2000-08-16
IT1290839B1 (it) 1998-12-14
SK13097A3 (en) 1997-08-06
DK10697A (da) 1997-04-01
ES2137886A1 (es) 1999-12-16
GB9627127D0 (en) 1997-02-19
MC2418A1 (fr) 1997-05-23
GB2304340A (en) 1997-03-19
NO970437L (no) 1997-02-20

Similar Documents

Publication Publication Date Title
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
BR9508948A (pt) Agulha para uso na distribuição sem vareta de prendedores plásticos
FI942092A (fi) Hallitusti vapauttava valmiste
BR9611377A (pt) Inibidor de trombina de ligação não lenta processo para preparar o mesmo composição farmacêutica e uso do inibidor de trombina
KR950704251A (ko) 프롤릴 엔도펩티다아제 억제 활성을 갖는 화합물 및 그 약학적 용도(compound with prolyl endopeptdase inhibitor activity and pharmaceutical use thereof)
DE69725804D1 (de) Hydroxycarbonsäure oder Retinoid enthaltende kosmetische Zusammensetzungen
CO5060502A1 (es) Mezclas insecticidas sinergicas que comprenden espinosad y un cloronicotinilo
MX173582B (es) Espesante de arcilla para emplear en sistemas basados en agua y compuestos de union que contienen esas composiciones
BR9510378A (pt) Novos agentes sinérgicos par combater insetos e ácaros
ID967B (id) Proses dan alat untuk membuat asam tereftalat
ID25752A (id) Senyawa-senyawa piretroid dan komposisi untuk mengontrol hama yang mengandung senyawa-senyawa tersebut
FI951009A0 (fi) Muskariinin vastaisina aineina käyttökelpoisia diaryylipiperatsinoasetamidiyhdisteitä
BR9505910A (pt) Processo para inibir a reabsorção de corantes migratórios nas águas residuais composição processo para a preparação de um detergente e composto
DE69520056T2 (de) Verbindungen zur Hemmung von Thrombin
BR9811458A (pt) "sistema solvente para penetração melhorada de compostos farmacêuticos"
AR002253A1 (es) Compuesto derivado de fenil-alcanol biocida composición que lo contiene y procesos para producirlo
PT101179A (pt) Composicoes desodorizantes que contem materiais para inibir a aderencia bacteriana, seu metedo de utilizacao e metodo para a determinacao de materiais que inibem a aderencia bacteriana
DE69801941T2 (de) Kautschukzusammensetzungen welche o-Salicylsalicylicsäure enthalten
BR9606409A (pt) Composto opticamente ativo composição farmacêutica processos para inibir agregação de plaqueta em um animal de sangue quente ligação de fibrinogênio a gpiib/iia em um animal de sangue quente e eventos trombóticos que acompanham agnina instável em animal de sangue quente e uso do composto opticamante ativo
CO4761022A1 (es) Pesticidas que contienen alcaloides de benzofenantridina
DE69418042T2 (de) Konservierungsstabile aktivierungszusammensetzung mit titanphosphat
EP0867168A3 (fr) Compositions topiques comprenant des substances actives sensibles à l'oxydation
BR9304420A (pt) Composiçao inseticida
MX14512A (es) Composicion fotopolimerizable y articulo que comprende la composicion.
ID22603A (id) Senyawa piretroid dan komposisi yang mengandung senyawa untuk mengendalikan hama

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal